文献速递心脏核医学骨显像与常规 SPECT

早期99mTc-HMDP SPECT/CT显示的心外软组织摄取有助于心脏淀粉样变性分型并具有高预后价值

Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-03-10

研究回顾8年间因怀疑心脏淀粉样变性行早期99mTc-HMDP闪烁显像的308例患者,其中247例为心脏淀粉样变性(75例ATTRv、107例ATTRwt、65例AL),61例为其他心脏病对照。心外摄取在心脏淀粉样变性中占29%、对照中占3%,肝脾摄取仅见于AL型;结合心外与心脏摄取的新型MADI指数对分型有高预测价值,MADI>0 vs MADI0在AL型及MADI3 vs MADI2在ATTR型与更差预后相关。

要点

  • 心外软组织摄取见于29%心脏淀粉样变性患者 vs 3%对照,最常见部位为胸膜肺(16% vs 3%)。
  • 肝脾心外摄取仅见于AL型心脏淀粉样变性(n=8)。
  • MADI1主要见于AL型(PPV=91%),MADI2/3多见于ATTR型(PPV=97%),P<0.0001。

核心结论

  • 心外摄取联合心脏摄取在心脏淀粉样变性患者中具有高诊断和预后价值。
  • MADI似乎是一个临床实践中简便可靠的评分。

研究设计与样本

  • 回顾性分析8年期间因怀疑心脏淀粉样变性转诊并接受99mTc-HMDP闪烁显像的全部患者。
  • 共308例符合条件患者,247例为心脏淀粉样变性(75例ATTRv、107例ATTRwt、65例AL),61例为其他心脏病对照。
  • MADI定义:MADI0为无ECU且无CU,MADI1为仅有ECU,MADI2为仅有CU,MADI3为ECU+CU。

主要发现

  • ECU见于29%的心脏淀粉样变性患者和3%的对照。
  • ECU最常见部位为胸膜肺(心脏淀粉样变性16% vs 对照3%),其次为消化道和皮下组织。
  • 肝和脾ECU仅见于AL型心脏淀粉样变性(n=8)。
  • CU仅见于心脏淀粉样变性患者(n=187),其中182例为ATTR型 vs 5例AL型,P<0.001。
  • MADI0仅见于对照(97%)和AL型心脏淀粉样变性(60%);MADI1主要见于AL型(PPV=91%),MADI2/3多见于ATTR型(PPV=97%),P<0.0001。

关键数值与推荐

  • ECU在心脏淀粉样变性中占29%、对照中占3%。
  • 胸膜肺ECU在心脏淀粉样变性中占16%、对照中占3%。
  • CU仅见于心脏淀粉样变性患者(n=187),其中ATTR型182例 vs AL型5例,P<0.001。
  • MADI1对AL型的PPV=91%,MADI2/3对ATTR型的PPV=97%,P<0.0001。
  • MADI>0 vs MADI0在AL型中与更差预后相关(P=0.03),MADI3 vs MADI2在ATTR型中与更差预后相关(P=0.002)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Increased cardiac uptake (CU) on early-phase 99mTc-HMDP scintigraphy has demonstrated diagnostic and prognostic values in amyloid transthyretin (ATTR) cardiac amyloidosis (CA). Extracardiac uptake (ECU) has been poorly studied. We assessed the clinical value of ECU, in combination with CU, on 99mTc-HMDP scintigraphy using a novel Methodological Amyloidosis Diagnostic Index (MADI). METHODS: We reviewed all patients referred for suspicion of CA, who underwent 99mTc-HMDP scintigraphy over an 8-year period. ECU, CU, and MADI were determined: MADI0 = neither ECU or CU, MADI1 = ECU alone, MADI2 = CU alone, and MADI3 = ECU + CU. RESULTS: Of 308 eligible patients, 247 had CA, including 75 ATTRv, 107 ATTRwt, and 65 light-chain (AL), while 61 had another cardiopathy (controls). ECU was observed in 29% of CA and 3% of controls. Most frequent sites of ECU were pleuropulmonary (16% of CA, 3% of controls) followed by the digestive tract and subcutaneous tissues. The liver and spleen ECU was only observed in AL-CA (n = 8). CU was only observed in CA patients (n = 187), of whom 182 had ATTR-CA vs. 5 AL-CA, P < 0.001. MADI0 was only observed in controls (97%) and in AL-CA (60%). MADI1 was mainly observed in AL-CA (positive predictive value, PPV = 91%) while MADI2/3 were more frequent in ATTR-CA (PPV = 97%), P < 0.0001. MADI > 0 vs. MADI0 in AL and MADI3 vs. MADI2 in ATTR were associated with a worse prognosis (P = 0.03 and P = 0.002, respectively). CONCLUSIONS: ECU combined with CU demonstrates high diagnostic and prognostic values in CA patients. MADI seems an easy and reliable score in clinical practice.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Malka N, Abulizi M, Kharoubi M, et al. Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value. Eur J Nucl Med Mol Imaging. 2020. PMID: 32157431. doi:10.1007/s00259-020-04753-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。